GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TerrAscend Corp (OTCPK:TSNDF) » Definitions » Institutional Ownership

TSNDF (TerrAscend) Institutional Ownership : 8.27% (As of Mar. 03, 2025)


View and export this data going back to 2017. Start your Free Trial

What is TerrAscend Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, TerrAscend's institutional ownership is 8.27%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, TerrAscend's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, TerrAscend's Float Percentage Of Total Shares Outstanding is 37.37%.


TerrAscend Institutional Ownership Historical Data

The historical data trend for TerrAscend's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TerrAscend Institutional Ownership Chart

TerrAscend Historical Data

The historical data trend for TerrAscend can be seen below:

2024-04-30 2024-05-31 2024-06-30 2024-07-31 2024-08-31 2024-09-30 2024-10-31 2024-11-30 2024-12-31 2025-01-31
Institutional Ownership 12.45 13.13 13.24 13.42 14.13 14.27 14.67 14.86 14.86 16.85

TerrAscend Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


TerrAscend Business Description

Traded in Other Exchanges
Address
77 City Centre Drive, Suite 501, East Tower, Mississauga, ON, CAN, L5B 1M5
TerrAscend Corp is a company focused on creating and delivering quality cannabis products and services that meet the evolving needs of its patients. It also provides education and support programs to physicians and patients through healthcare professionals. It has one operating segment, being cultivation, production, and sale of cannabis products, with subsidiaries located in Canada and the United States.